Serous Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Serous Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression [Phase 2]
Phase 2 study investigating niraparib rechallenge after surgery in ovarian cancer patients with oligometastatic progression; currently recru…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study of Isoquercetin in People With Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating isoquercetin in patients with ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer [Phase 2]
This Phase 2 clinical trial evaluates regorafenib in combination with fulvestrant for recurrent low-grade serous ovarian cancer and is curre…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer [Phase 1]
Phase 1 trial update for huCART-meso plus VCN-01 in pancreatic cancer and serous ovarian cancer; the study is currently active but not recru…
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer [Phase 3]
A Phase 3 clinical trial evaluating paclitaxel lipid suspension for platinum-resistant or refractory ovarian cancer and related platinum-res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for SC0191 combined with chemotherapy in advanced serous ovarian cancer, currently in Phase 1/Phase 2, sponsor Biocity…
-
CLINICAL_TRIALS trial_result · 2015-12-01Clinical Trial Update: Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating erlotinib in combination with carboplatin and paclitaxel in ovarian and related cancers. The study has completed an…